 |
인쇄하기
취소
|
Yuhan, Boehringer Ingelheim Korea to co-market Twynsta in Korea
Yuhan Corp. and Boehringer Ingelheim Korea announced on October 5 that the two companies have signed an agreement to co-market Twynsta (telmisartan/amlodipine) in Korea.
The domestic hypertension market is estimated at 1.4 trillion won. The medicine has been available from November 2009 in the following strengths: 40/5 mg, 40/10 mg, 80/5 mg, 80/10 mg.
Twynsta is an angiotensin II recepto...
The domestic hypertension market is estimated at 1.4 trillion won. The medicine has been available from November 2009 in the following strengths: 40/5 mg, 40/10 mg, 80/5 mg, 80/10 mg.
Twynsta is an angiotensin II recepto...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.